Rosetta Genomics Expects $27.7M in Net Proceeds from Public Offering

Jul 26, 2012

|

NEW YORK (GenomeWeb News) – Rosetta Genomics said in a regulatory filing on Thursday that it anticipates raising about $27.7 million in a public offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

French Funding Agency Head Resigns

The president of France's National Research Agency has resigned, according to Nature News.

Right to Try Versus Clinical Trials

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.